Results 251 to 260 of about 47,521 (285)

Progress and Prospects of Persistent Luminescent Nanocrystals in Biomedical Applications

Advanced Optical Materials, Volume 14, Issue 6, 9 February 2026.
This review summarizes recent progress in materials‐level control of persistent luminescence, including mechanistic understanding, wavelength/intensity tuning, and activation strategies, as well as emerging biomedical applications in imaging, biosensing, cell tracking, optogenetic stimulation, and biophotochemical activation.
Peng Pei, Luping Wang, Haitong Jing, Xian Qin, Jiong‐Wei Wang, Xiaogang Liu   +5 more
wiley   +1 more source

An efficacious opportunity for diagnosis and treatment of cancers: Radiolabeled fibroblast activation protein (FAP) inhibitors. [PDF]

Bioimpacts
Vahidfar N, Aghanejad A.
europepmc   +1 more source

NIR Ratiometric Fluorescent Antibody‐Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring

Advanced Science, Volume 13, Issue 7, 3 February 2026.
In vivo optical imaging enhances antibody‐drug conjugate (ADC) optimization by enabling real‐time monitoring of stimulus‐responsive drug behavior. We report n501‐CYMMAF, a ratiometric theranostic with strong target affinity and low‐dose efficacy for ovarian metastasis.
Cheng Li, Zezhong Yu, Tao Pu, Yanling Wu, Gang Wang, Youhua Xie, Tianlei Ying, Zhenlin Yang, Yibing Shi   +8 more
wiley   +1 more source

Radiolabeling and evaluation of ⁶⁴⁺⁶⁷Cu-2,2'-(1,2,4-Oxadiazole-3,5-diyl)di aniline as a theranostic agent for solid tumors. [PDF]

Sci Rep
Gizawy MA, Ayoup MS, Kodous AS, Abdelrahman MT, Motaleb MA.   +4 more
europepmc   +1 more source

Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy

Advanced Science, Volume 13, Issue 7, 3 February 2026.
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley   +1 more source

Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy. [PDF]

Cancers (Basel)
Ramonaheng K, Banda K, Qebetu M, Goorhoo P, Legodi K, Masogo T, Seebarruth Y, Mdanda S, Sibiya S, Mzizi Y, Davis C, Smith L, Ndlovu H, Kabunda J, Maes A, Van de Wiele C, Al-Ibraheem A, Sathekge M.   +17 more
europepmc   +1 more source

Radiocobalt theranostic applications: current landscape, challenges, and future directions. [PDF]

Front Nucl Med
Sanwick AM, Chaple IF.
europepmc   +1 more source

Transepithelial corneal cross-linking: a review. [PDF]

Int Ophthalmol
Zhou W, Subasinghe SK, de Ribot FM, Ogbuehi KC, Dias GJ.   +4 more
europepmc   +1 more source

Nanotechnology Driven Innovations in Modern Pharmaceutics: Therapeutics, Imaging, and Regeneration. [PDF]

Nanomaterials (Basel)
Parvin N, Aslam M, Alam MN, Mandal TK.
europepmc   +1 more source

Therapeutic and diagnostic implications of exosomes as natural nanoparticles: a new paradigm in brain cancer disease management. [PDF]

Front Med (Lausanne)
Mohiyuddin S, Dipankar P, Robinson B, Jeyabose A, Karthikeyan J.   +4 more
europepmc   +1 more source